Company Overview of GenSight Biologics SA
GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery and development of therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. The company develops its products through gene therapy-based approach with technology platforms of mitochondrial targeting sequence and optogenetics. Its lead product candidates include GS010, an AAV2 containing the human wild-type ND4 gene, which is in Phase Ib clinical trials for the treatment of Leber Hereditary Optic Neuropathy associated with mutation in the ND4 gene; and GS030 that comprises a gene encoding a photoactivatable channelrhodopsin for the treatment of reinitis pigmentosa...
74, rue du Faubourg Saint-Antoine
Key Executives for GenSight Biologics SA
Co-Founder, Executive Chairman and Chief Executive Officer
Scientific Founder, Vice Chairman of Scientific & Clinical Advisory Board and Board Observer
Scientific Founder and Chairman of Scientific & Clinical Advisory Board
Scientific Founder and Vice Chairman of Scientific & Clinical Advisory Board
Scientific Founder and Member of Scientific & Clinical Advisory Board
Compensation as of Fiscal Year 2015.
GenSight Biologics SA Key Developments
GenSight Biologics SA Appoints Thomas Gidoin as Chief Financial Officer & Michael Wyzga to Board of Directors
Jul 6 15
GenSight Biologics SA announced the appointments of Thomas Gidoin as Chief Financial Officer and Michael Wyzga as Independent Director. In this role, Mr. Gidoin is responsible for the company’s corporate and financial development strategies and operations, and will report to Dr. Bernard Gilly, Chief Executive Officer and Chairman of GenSight. Mr. Gidoin brings significant corporate finance and leadership experience to GenSight. Since 2012, he led the Corporate Finance team at DBV Technologies, participating in public offerings and private placements, including the dual listing of the company on the NASDAQ Global Select Market. Prior to that, he worked at Ipsen from 2008 to 2011, as a Senior Financial Analyst within the Group Operations division and later as UK Operations
Controller in London. Mr. Gidoin holds Master’s degrees in International Finance from ESGF Paris and in International Management from Neoma Business School in France.
GenSight Biologics SA Presents at Leerink's Global Healthcare Conference, Feb-12-2015 08:55 AM
Jan 30 15
GenSight Biologics SA Presents at Leerink's Global Healthcare Conference, Feb-12-2015 08:55 AM. Venue: Waldorf Astoria New York, New York, New York, United States.
GenSight Biologics SA Presents at BIO-Europe Spring 2015, Mar-09-2015 through Mar-11-2015
Jan 29 15
GenSight Biologics SA Presents at BIO-Europe Spring 2015, Mar-09-2015 through Mar-11-2015. Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France. Presentation Date & Speakers: Mar-09-2015, Jean-Philippe Combal, Chief Operating Officer. Mar-11-2015.
Similar Private Companies By Industry
Recent Private Companies Transactions
July 7, 2015